SPONSOR
Dwight Owen
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Extensive Stage Lung Small Cell CarcinomaMetastatic Lung Small Cell CarcinomaRecurrent Lung Small Cell CarcinomaStage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8
NCT06616623 Phase 1
Recruiting
Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
Metastatic Lung Non-Small Cell Carcinoma
NCT04919382 Phase 2
Recruiting
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Extensive Stage Lung Small Cell Carcinoma